drug
ritonavir
Marketedupdated 3mo agoby Quagen Pharmaceuticals LLC
Approvedcommunity read0 votes
🐶 often sniffed alongside
top 8- drugALDACTAZIDE2 co-mentions · 1 sources
- drugZestril2 co-mentions · 1 sources
- drugRitonavir Cipla2 co-mentions · 2 sources
- drugLOPINAVIR AND RITONAVIR2 co-mentions · 1 sources
- tagApproval2 co-mentions · 1 sources
- druglisinopril2 co-mentions · 1 sources
- companyMicro Labs Ltd1 co-mentions · 1 sources
- tagSmall Molecule1 co-mentions · 1 sources
all catalysts(0)
nothing on the calendar yet
Trials studying ritonavir
- phase4A Study to Provide Continued Access to Study Drug to Children and Adolescents Who Have Completed Clinical Studies Involving Gilead HIV Treatments
- phase2A Study of the Preliminary Efficacy of DARE-HPV to Treat High-risk Persistent Human Papillomavirus (hrHPV)
- phase3Once Daily Dosing of Lonafarnib Co-administered With Ritonavir for Treatment of Chronic Hepatitis D Virus Infection
- phase3Study Comparing Efficacy and Safety of Darunavir Boosted With Ritonavir to HART With 2 NRTI and Darunavir Boosted With Ritonavir in HIV-1 Infected Patients ANRS136
- phase3Prevention of HIV1 Mother to Child Transmission Without Nucleoside Analogue Reverse Transcriptase Inhibitors in the Pre-partum Phase. ANRS 135 Primeva
- phase2Measure of Pharmacokinetic Parameters and Adherence With MEMS in Naive HIV Infected Patients Treated With Reyataz Once Daily Combined With Norvir and Truvada
- phase4A Trial of 2 Options for Second Line Combination Antiretroviral Therapy Following Virological Failure of a Standard Non-nucleoside Reverse Transcriptase Inhibitor (NNRTI)+2N(t)RTI First Line Regimen
- —A US Study to Look at Loss of Work and Healthcare Costs for People Affected With Mild-to-moderate COVID 19 Who Have High Chances of the Disease Becoming Severe
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 56m ago
Found something off?
comments(0)
5-min edit window · permanent after that